Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsIndependent Health step therapy Prior Auth | OpenP…
    Ask Trek AI about this page

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    CurrentIndependent HealthPolicy N/A

    Step therapy criteria for formulary medications

    Customize your policy alerts

    Sign up for all Independent Health policy alerts

    Know when Independent Health releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines step therapy requirements for medications on Independent Health 2026 formularies and explains when prior authorization is required based on a member's prescription history; applies to providers, pharmacies, and members covered under Independent Health formularies.

    Policy Summary
    PayerIndependent Health
    PolicyStep therapy criteria for formulary medications
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateMay 1, 2026
    Next Review DateN/A
    Key ActionIf the member's pharmacy history does not show the specified prior fill within the product-specific lookback window, submit a prior authorization request.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    Multipleformulary medications listed with step therapy rules
    90-365 dayslookback windows used for prior-fill requirements
    4Independent Health formularies referenced
    30-365 daysautomated approval lookback range
    120 dayshigh-potency narcotics lookback

    Product-specific Coverage and Routing Rules

    Product-specific step therapy coverage

    Covered when ALL of the following are met for the specific product:

    prior-fill requirement example: Member's pharmacy profile documents a specified prior fill or concurrent medication within the product-specific lookback window (e.g., generic alternative filled within 90/180/365 days or concurrent levodopa/carbidopa use).see thresholds per product

    If this condition is not met, prior authorization is required.

    Automated prior-fill coverage pass

    Covered (passes online) when ANY one prior-fill condition is met for the specific product within its lookback window; otherwise prior authorization is required.

    prior-fill-pass: Patient pharmacy history documents fill of specified comparator/prerequisite medication within the stated lookback window (product-specific).product-specific (30-365 days)
    Policy Summary
    PayerIndependent Health
    PolicyStep therapy criteria for formulary medications
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateMay 1, 2026
    Next Review DateN/A
    Key ActionIf the member's pharmacy history does not show the specified prior fill within the product-specific lookback window, submit a prior authorization request.
    SourceLink
    On This Page
    Product-specific Coverage and Routing RulesAffected Product Listings and Lookback WindowsPrior Authorization Triggers and Required DocumentationFill-History Based Initial Processing RulesStep Requirements and ExceptionsPolicy Rationale and DefinitionsPolicy Versions and Updates

    If this condition is true the prescription 'goes through online' and PA is not required.

    Initial Processing Criteria (Fill-history based)

    Covered when ALL of the following are met for each product entry:

    General fill-history rule: Patient's Independent Health prescription history documents the specified prior medication fill within the product-specific look-back windowsee thresholds per product

    If this condition is not met prior authorization is required

    Trintellix routing criteria

    Covered when conditions in routing criteria are met; otherwise prior authorization required

    Trintellix 5 mg routing: Prescription is routed online if Independent Health prescription history documents a fill of a generic SSRI (e.g., sertraline, fluoxetine, escitalopram) within the previous 90 days.90 days

    If criterion not met, prior authorization required

    Febuxostat routing criteria

    Febuxostat routing: Prescription is routed online if Independent Health prescription history documents that allopurinol was filled within the previous 90 days.90 days

    If criterion not met, prior authorization required

    Xphozah routing criteria

    Xphozah routing: Prescription is routed online if Independent Health prescription history documents concurrent (within the previous 120 days) use of a phosphate binder.120 days

    If not documented, prescriber may request authorization via standard process

    Zolpidem sublingual routing criteria

    Zolpidem sublingual routing: Prescription is routed online if Independent Health prescription history documents that generic zolpidem was filled within the previous 90 days.90 days

    If criterion not met, prior authorization required

    Starting any of the listed high‑potency narcotics in a patient with no recent narcotic use will trigger prior authorization. Specifically, these products will only "go through online" (process without prior authorization) when the member's Independent Health pharmacy history documents a narcotic medication fill within the previous 120 days. If the pharmacy profile does not show a qualifying narcotic fill in that lookback window, prior authorization is required before the prescription can be dispensed.

    For aliskiren entries, the claim will only process online when the member's Independent Health pharmacy history documents fills for both an ACE inhibitor and an ARB within the previous 180 days. If the pharmacy profile does not show both an ACE and an ARB filled in that 180‑day lookback, prior authorization is required.

    Affected Product Listings and Lookback Windows

    Products AffectedNDC | product text
    EUCRISA OINTMENT 2 % EXTERNALproduct listed
    Products AffectedNDC | product text
    FETZIMA CAPSULE EXTENDED RELEASE 24 HOUR 120 MG ORALproduct listed
    FETZIMA CAPSULE EXTENDED RELEASE 24 HOUR 20 MG ORALproduct listed
    FETZIMA CAPSULE EXTENDED RELEASE 24 HOUR 40 MGproduct listed
    FETZIMA CAPSULE EXTENDED RELEASE 24 HOUR 80 MG ORALproduct listed
    FETZIMA TITRATION CAPSULE ER 24 HOUR THERAPY PACK 20 & 40 MG ORALproduct listed
    Products AffectedNDC | product text
    glycopyrrolate soluon 1 mg/5ml oralproduct listed
    Products AffectedNDC | product text
    doxercalciferol capsule 0.5 mcg oralproduct listed
    doxercalciferol capsule 1 mcg oralproduct listed
    doxercalciferol capsule 2.5 mcg oralproduct listed
    RAYALDEE CAPSULE EXTENDED RELEASE 30 MCG ORALproduct listed
    Products AffectedNDC | product text
    amphet-dextroamphet 3-bead er capsule extended release 24 hour 12.5 mg oralproduct listed
    amphet-dextroamphet 3-bead er capsule extended release 24 hour 25 mg oralproduct listed
    amphet-dextroamphet 3-bead er capsule extended release 24 hour 37.5 mg oralproduct listed
    amphet-dextroamphet 3-bead er capsule extended release 24 hour 50 mg oralproduct listed
    Products AffectedNDC | product text
    memanne hcl-donepezil hcl er capsule extended release 24 hour 14-10 mg oralproduct listed
    memanne hcl-donepezil hcl er capsule extended release 24 hour 21-10 mg oralproduct listed
    memanne hcl-donepezil hcl er capsule extended release 24 hour 28-10 mg oralproduct listed
    NAMZARIC CAPSULE EXTENDED RELEASE 24 HOUR 7-10 MG ORALproduct listed
    High-potency narcoticsNDC | product text
    fentanyl patch 72 hour 100 mcg/hr transdermalproduct listed
    fentanyl patch 72 hour 12 mcg/hr transdermalproduct listed
    fentanyl patch 72 hour 25 mcg/hr transdermalproduct listed
    fentanyl patch 72 hour 50 mcg/hr transdermalproduct listed
    fentanyl patch 72 hour 75 mcg/hr transdermalproduct listed
    hydrocodone bitartrate er tablet er 24 hour abusedeterrent 100 mg oralproduct listed
    hydrocodone bitartrate er tablet er 24 hour abusedeterrent 120 mg oralproduct listed
    hydrocodone bitartrate er tablet er 24 hour abusedeterrent 20 mg oralproduct listed
    hydrocodone bitartrate er tablet er 24 hour abusedeterrent 30 mg oralproduct listed
    hydrocodone bitartrate er tablet er 24 hour abusedeterrent 40 mg oralproduct listed
    1–10 of 35
    1/4
    Products AffectedNDC | product text
    ONGENTYS CAPSULE 25 MG ORALproduct listed
    ONGENTYS CAPSULE 50 MG ORALproduct listed
    Products AffectedNDC | product text
    ORAVIG TABLET 50 MG BUCCALproduct listed
    Products AffectedNDC | product text
    oxcarbazepine er tablet extended release 24 hour 150 mg oralproduct listed
    oxcarbazepine er tablet extended release 24 hour 300 mgproduct listed
    oxcarbazepine er tablet extended release 24 hour 600 mg oralProduct listed
    Products AffectedNDC | text
    QELBREE CAPSULE EXTENDED RELEASE 24 HOUR 100 MG ORALProduct listed
    QELBREE CAPSULE EXTENDED RELEASE 24 HOUR 150 MGProduct listed
    QELBREE CAPSULE EXTENDED RELEASE 24 HOUR 200 MG ORALProduct listed
    Products AffectedNDC | text
    QUILLICHEW ER TABLET CHEWABLE EXTENDED RELEASE 20 MG ORALProduct listed
    QUILLICHEW ER TABLET CHEWABLE EXTENDED RELEASE 30 MG ORALProduct listed
    QUILLICHEW ER TABLET CHEWABLE EXTENDED RELEASE 40 MG ORALProduct listed
    QUILLIVANT XR SUSPENSION RECONSTITUTED ER 25 MG/5ML ORALProduct listed
    Products AffectedNDC | text
    aliskiren fumarate tablet 150 mg oralProduct listed
    aliskiren fumarate tablet 300 mg oralProduct listed
    Products AffectedNDC | text
    SANCUSO PATCH 3.1 MG/24HR TRANSDERMALProduct listed
    Products AffectedNDC | text
    SEREVENT DISKUS AEROSOL POWDER BREATH ACTIVATED 50 MCG/ACT INHALATIONProduct listed
    Products AffectedNDC | text
    tazarotene cream 0.05 % externalProduct listed
    tazarotene cream 0.1 % externalProduct listed
    tazarotene gel 0.05 % externalProduct listed
    tazarotene gel 0.1 % externalProduct listed
    Products AffectedNDC | text
    tramadol hcl er tablet extended release 24 hour 100 mg oralProduct listed
    tramadol hcl er tablet extended release 24 hour 200 mgProduct listed
    tramadol hcl er tablet extended release 24 hour 300 mg oralProduct listed
    Products AffectedNDC | text
    TRINTELLIX TABLET 10 MG ORALProduct listed
    TRINTELLIX TABLET 20 MG ORALProduct listed
    TRINTELLIX TABLET 5 MG ORALProduct listed
    Uloric (febuxostat) Products AffectedNDC | text
    febuxostat tablet 40 mg oralproduct listed
    febuxostat tablet 80 mg oralproduct listed
    Trintellix product listingmixed
    No codes listed
    Uloric (febuxostat) product listingmixed
    No codes listed
    Xphozah (tenapanor) product listingmixed
    No codes listed
    Zolpidem tartrate sublingual product listingmixed
    No codes listed
    GLP-1 lookback
    GLP-1 oral/medication trial lookback130 days
    Common prior-fill lookback
    Common prior-fill lookback (used for many generic/alternative trials)90 days
    NSAID / Ondansetron lookback
    NSAID/ondansetron prior-fill lookback180 days
    Zolpidem lookback
    Zolpidem prior-fill lookback (for Belsomra entries)365 days
    NSAID lookback
    NSAID lookback (generic NSAID trial for select products)180 days
    Topical immunomodulator / corticosteroid lookback
    Topical immunomodulator / topical corticosteroid lookback365 days
    Common oral product lookback
    Common oral product lookback (venlafaxine XR, glycopyrrolate, calcitriol, amphetamine-DEX forms, donepezil/memantine combos etc.)90 days
    High-potency narcotics lookback
    High-potency narcotics lookback (narcotic fills required before initiating listed high-potency agents)120 days
    ORAVIG antifungal lookback
    ORAVIG antifungal lookback (clotrimazole troches, fluconazole, or nystatin oral suspension)30 days
    ONGENTYS adjunct therapy lookback
    ONGENTYS adjunct therapy lookback (entacapone or levodopa/carbidopa-entacapone concurrent use)180 days
    Clotrimazole / fluconazole / nystatin look-back
    Clotrimazole / fluconazole / nystatin lookback30 days
    Oxcarbazepine look-back
    Oxcarbazepine prior-fill lookback90 days
    Methylphenidate SR/XR look-back
    Methylphenidate SR/XR lookback120 days
    ACE and ARB concurrent fills lookback
    ACE and ARB concurrent fills lookback (for aliskiren)180 days
    Ondansetron lookback
    Ondansetron lookback (for Sancuso patch)180 days
    Tretinoin / Adapalene lookback
    Tretinoin / adapalene prior-fill lookback (for tazarotene topical products)90 days
    Immediate-release tramadol lookback
    Immediate-release tramadol prior-fill lookback (for tramadol ER routing)90 days
    Generic SSRI or Allopurinol lookback
    Generic SSRI or allopurinol prior-fill lookback (Trintellix / febuxostat routing)90 days

    Prior Authorization Triggers and Required Documentation

    Prior Authorization

    Prior Authorization Triggers and Required Documentation

    Prior authorization is required when the member's Independent Health pharmacy profile does not document the specified prior fill or concurrent medication within the product-specific lookback window. When the required fill(s) are present in the Independent Health prescription history within the stated lookback period, the prescription will process online without a prior authorization.

    • EUCRISA: PA required if no generic NSAID fill in prior 180 days.
    • Topical immunomodulator/corticosteroid products: PA required if no tacrolimus, pimecrolimus, or topical corticosteroid fill in prior 365 days.
    • Glycopyrrolate products: PA required if no generic glycopyrrolate tablet fill in prior 90 days.
    • Doxercalciferol products: PA required if no calcitriol fill in prior 90 days.
    • Amphetamine–dextroamphetamine ER products: PA required if no amphetamine–dextroamphetamine ER capsule fill in prior 90 days.
    • Memantine/donepezil combination products (e.g., Namzaric): PA required if no donepezil or memantine fill in prior 90 days.
    • High‑potency extended‑release narcotics: PA required if no narcotic medication fill in prior 120 days.
    • Formulary notes: Medications that require step therapy are marked with 'ST' in the formulary; contact Member Services at 1-800-501-3439 (TTY 711) for questions.
    • Automated fill-history step checks: prescriptions will "go through online" (no PA) when the patient's Independent Health prescription history documents the required prior fills or concurrent therapies within the product-specific lookback windows.
    • Fill-history step rules: each listed product has a step‑therapy style rule — the prescription processes without PA only if the Independent Health pharmacy profile shows the qualifying prior fill(s) within the specified lookback period; otherwise prior authorization must be submitted.

    Fill-History Based Initial Processing Rules

    Dapsone gel (Aczone) initial requirement

    Initial pharmacy-fill-based step requirement

    dapsone gel 7.5%: Patient's Independent Health prescription history documents a fill for generic dapsone 5% within the previous 90 days.90 days

    If not documented, prior authorization is required.

    Belsomra initial requirement

    Initial pharmacy-fill-based step requirement

    Belsomra: Pharmacy history documents a generic zolpidem fill within the previous 365 days.365 days

    If not documented, prior authorization is required.

    Initial therapy screening

    Initial dispensing decision based on recent pharmacy history

    initial-fill-pass: Presence of specified prior fill within product-specific lookback window allows online dispensing without PA.product-specific

    If absent, prior authorization required.

    Clotrimazole/Fluconazole/Nystatin rule

    Processing allowed without prior authorization when prior-fill criteria met

    clotrimazole/fluconazole/nystatin prior fill: A prior fill of clotrimazole troches, fluconazole, or nystatin oral suspension within 30 days30 days

    If met, prescription processes online; if not, prior authorization required.

    Oxcarbazepine rule

    oxcarbazepine prior fill: Oxcarbazepine filled within the previous 90 days90 days

    If met, prescription processes online; otherwise prior authorization required.

    Methylphenidate SR/XR rule

    methylphenidate SR/XR prior fill: Generic methylphenidate slow-release or extended release product filled within the previous 120 days120 days

    If met, prescription processes online; otherwise prior authorization required.

    Aliskiren rule

    ACE and ARB prior fills: An ACE inhibitor and an ARB were filled within the previous 180 days180 days

    If met, prescription processes online for aliskiren; otherwise prior authorization required.

    Sancuso rule

    ondansetron prior fill: Ondansetron filled within the previous 180 days180 days

    If met, Sancuso patch processes online; otherwise prior authorization required.

    Serevent Diskus rule

    concurrent inhaled corticosteroid or Spiriva: Pharmacy history documents concurrent use of inhaled corticosteroid or tiotropium (Spiriva)N/A

    If met, Serevent Diskus processes online; otherwise prior authorization required.

    Tazarotene topical rule

    tretinoin or adapalene prior fill: Tretinoin or adapalene was filled within the previous 90 days90 days

    If met, tazarotene topical products process online; otherwise prior authorization required.

    Tramadol ER rule

    immediate-release tramadol prior fill: Immediate release tramadol filled within the previous 90 days90 days

    If met, tramadol ER processes online; otherwise prior authorization required.

    Trintellix rule

    generic SSRI prior fill: Generic SSRI antidepressant (e.g., sertraline, fluoxetine, escitalopram) filled within the previous 90 days90 days

    If met, Trintellix processes online; otherwise prior authorization required.

    Febuxostat (Uloric) rule

    allopurinol prior fill: Allopurinol filled within the previous 90 days90 days

    If met, febuxostat (Uloric) processes online; otherwise prior authorization required.

    Trintellix initial therapy

    Routing based on prior medication fills

    Trintellix initial routing: Requires documented generic SSRI fill within prior 90 days to route online; otherwise PA required.

    Febuxostat initial therapy

    Febuxostat initial routing: Requires documented allopurinol fill within prior 90 days to route online; otherwise PA required.

    Xphozah initial therapy

    Xphozah initial routing: Requires documented concurrent phosphate binder use within prior 120 days to route online; otherwise prescriber must request authorization.

    Zolpidem sublingual initial therapy

    Zolpidem sublingual initial routing: Requires documented generic zolpidem fill within prior 90 days to route online; otherwise PA required.

    Step Requirements and Exceptions

    Step requirementNotes
    Trial of an oral antidiabetic agent (excluding metformin) or documentation of type 2 diabetes in the member's Independent Health prescription historyLookback window: 130 days; if criterion not met, prior authorization is required.
    Coverage passes online when history shows type 2 diabetes or a trial of any oral antidiabetic (excl. metformin)Source criteria: GLP-1 product routing based on prior-fill documentation.
    Step requirementNotes
    Concurrent use of a levodopa/carbidopa product documented in the member's Independent Health prescription historyIf concurrent levodopa/carbidopa use is not documented, prior authorization is required.
    Step requirementNotes
    Trial of a generic nonsteroidal anti-inflammatory drug (NSAID) documented in pharmacy historyLookback window: previous 180 days; absence of a generic NSAID fill triggers prior authorization.
    Step requirementNotes
    Documented fill of the specified comparator or prerequisite medication within the product-specific lookback windowLookback window varies by product (commonly 30–365 days); if no qualifying prior fill is present, prior authorization is required.
    Step outcomeAction when criterion not met
    Prior authorization requiredA prescription will not pass automated online processing when the pharmacy profile does not show the specified prior fill within the lookback window.
    Step outcomeAction when criterion not met
    Prior authorization requiredIf no oxcarbazepine fill is documented within the previous 90 days, the claim requires prior authorization.
    Step outcomeAction when criterion not met
    Prior authorization requiredIf no generic methylphenidate SR/XR fill is documented within the previous 120 days, prior authorization is required.
    Step outcomeAction when criterion not met
    Prior authorization requiredIf ACE and ARB fills are not both documented within the previous 180 days for aliskiren entries, the prescription requires prior authorization.
    Step outcomeAction when criterion not met
    Prior authorization requiredIf ondansetron is not documented within the previous 180 days, the Sancuso patch claim will require prior authorization.
    Step outcomeAction when criterion not met
    Prior authorization requiredIf concurrent inhaled corticosteroid or tiotropium (Spiriva) use is not documented, Serevent Diskus will require prior authorization.
    Step outcomeAction when criterion not met
    Prior authorization requiredIf tretinoin or adapalene is not documented within the previous 90 days, tazarotene topical products require prior authorization.
    Step outcomeAction when criterion not met
    Prior authorization requiredIf immediate‑release tramadol is not documented within the previous 90 days, tramadol ER prescriptions require prior authorization.
    Step outcomeAction when criterion not met
    Prior authorization requiredIf the required generic SSRI (for Trintellix) or allopurinol (for febuxostat) fill is not documented within the prior 90 days, prior authorization is required.
    Trintellix requirementNotes
    Documented generic SSRI fill within the previous 90 days required to avoid prior authorizationTrintellix 5 mg is routed online only when pharmacy history documents a generic SSRI (e.g., sertraline, fluoxetine, escitalopram) filled within 90 days; otherwise PA required.
    Febuxostat requirementNotes
    Documented allopurinol fill within the previous 90 days required to avoid prior authorizationFebuxostat (Uloric) 40 mg and 80 mg route online when an allopurinol fill is documented within 90 days; otherwise PA required.
    Xphozah requirementNotes
    Documented concurrent phosphate binder use within the previous 120 days required to avoid prior authorizationIf concurrent phosphate binder use is not documented, prescriber may request authorization via the standard process.
    Zolpidem sublingual requirementNotes
    Documented generic zolpidem fill within the previous 90 days required to avoid prior authorizationSublingual zolpidem (1.75 mg and 3.5 mg) is routed online only if a generic zolpidem fill is present within 90 days; otherwise PA required.

    Policy Rationale and Definitions

    Step therapy is a utilization management approach that encourages trial of established, typically lower‑cost medications (commonly generics) before covering more expensive brand or specialty agents. Under these rules, a formulary product is covered without prior authorization only when the member's pharmacy history documents the specified comparator or prerequisite medication(s) within the product‑specific lookback window; otherwise a prior authorization is required.

    Definition: 'ST' (step therapy)
    'ST' formulary notationIndicates a medication requires step therapy on the formulary notes column
    Definition: 'goes through online'
    'Goes through online' definitionClaim passes automated screening based on prior fill history and does not require prior authorization

    Policy Versions and Updates

    5/1/2026policy_effectiveLatest

    Step therapy criteria list updated and published for Independent Health 2026 formularies (document current as of 5/1/2026).

    5/1/2026product_routing_update

    ONGENTYS routing criteria and QUILLICHEW/QUILLIVANT methylphenidate lookback entries referenced with 5/1/2026 date in document body.

    2026-05-01trintellix_routing

    Trintellix routing clarified: prescription routes online if generic SSRI documented within previous 90 days; otherwise prior authorization required.

    2026-05-01uloric_routing

    Febuxostat (Uloric) routing clarified: prescription routes online if allopurinol documented within previous 90 days; otherwise prior authorization required.

    2026-05-01xphozah_routing

    Xphozah routing clarified: prescription routes online if concurrent phosphate binder use documented within previous 120 days; prescriber may request authorization if not documented.

    2026-05-01zolpidem_sublingual_routing

    Sublingual zolpidem routes online if generic zolpidem documented within previous 90 days; otherwise prior authorization required.